Publicité

Professor Declan Devane - IPPOSI Patient Reported Outcome Measures conference Oct 2018

77 Camden Street, Dublin 2, D02XE80
25 Oct 2018
Publicité

Contenu connexe

Présentations pour vous(20)

Similaire à Professor Declan Devane - IPPOSI Patient Reported Outcome Measures conference Oct 2018(20)

Publicité
Publicité

Professor Declan Devane - IPPOSI Patient Reported Outcome Measures conference Oct 2018

  1. Core Outcomes in Clinical Trials Declan Devane Director, HRB-Trials Methodology Research Network Professor of Midwifery, NUI Galway
  2. The problem… • Variety of and inconsistency in outcomes reported in trials (and other studies); • Differences in how outcomes are defined and measured; • Differences in what different stakeholders judge to be important; • Studies reporting positive or significant results are more likely to be published • Outcomes that are statistically significant are more likely to be fully reported
  3. • Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD003641. DOI: 10.1002/14651858.CD003641.pub3 • ‘Several different measures of weight change were reported by the studies, namely BMI, change in BMI, weight, weight loss, percent weight loss, percent excess weight loss, fat mass, fat free mass, percent ideal body weight and proportion of ‘successes’…Quality of life was reported by just five studies…and co-morbidities were reported by eight studies.’
  4. Fishing for effect • The large ISIS-2 trial involved 17,000 patients with suspected heart attack who were randomised; – (i) Streptokinase (ii) aspirin (iii) both active treatments or (iv) neither. • Substantial beneficial effect for aspirin, comparable to the effect of streptokinase; • Authors then do a subgroup analysis……
  5. • “subdivision of the patients in ISIS-2 with respect to their astrological birth sign appears to indicate that for persons born under Gemini or Libra, there was a slightly adverse effect of aspirin on mortality (9% increase, SD 13; NS), while for patients born under all other astrological signs there was a striking beneficial effect (28% reduction, SD 5; 2p <0.00001).”
  6. Why have core outcome sets? • Several tens of thousands of research studies are underway and 500+ are published every week • Working through them is overwhelming and made worse by studies of the same topic describing findings in different ways • Systematic reviews might help but need to bring together and make sense of a variety of studies, using a variety of outcomes, measured in a variety of ways; and need to choose outcomes that the readers want to see • We need to be able to compare, contrast and combine research to improve health care and improve health
  7. What is a “core outcome set”? • An agreed standardised set of the most important (“core”) outcomes • Disease/condition specific (might cover all treatment types or a particular intervention) • Includes both benefits and harms • Measured and reported as the minimum (other outcomes will usually be collected) • Relevant to those making decisions about health care.
Publicité